Science 25 February 1983: Vol. 219. no. 4587, pp. 983 - 985 DOI: 10.1126/science.6823562

Prev | Table of Contents | Next

Articles

Basic Science Review: Current Insights on the Biology and Clinical Aspects of VEGF Regulation.

D. M. Birk, J. Barbato, L. Mureebe, and R. A. Chaer (2009)
Vascular and Endovascular Surgery 42, 517-530
 |  Abstract »  |  PDF »

Anti-angiogenic Therapy Against Gastrointestinal Tract Cancers.

J. Iwasaki and S.-i. Nihira (2009)
Jpn. J. Clin. Oncol.
 |  Abstract »  |  Full Text »  |  PDF »

Reduction in Levels of Plasma Vascular Endothelial Growth Factor-A and Improvement in Hydrocele Patients by Targeting Endosymbiotic Wolbachia sp. in Wuchereria bancrofti with Doxycycline.

A. Y. Debrah, S. Mand, Y. Marfo-Debrekyei, L. Batsa, K. Pfarr, B. Lawson, M. Taylor, O. Adjei, and A. Hoerauf (2009)
Am J Trop Med Hyg 80, 956-963
 |  Abstract »  |  Full Text »  |  PDF »

Vascular Endothelial Growth Factor.

N. Ferrara (2009)
Arterioscler. Thromb. Vasc. Biol. 29, 789-791
 |  Abstract »  |  Full Text »  |  PDF »

Satellite cell-mediated angiogenesis in vitro coincides with a functional hypoxia-inducible factor pathway.

R. P. Rhoads, R. M. Johnson, C. R. Rathbone, X. Liu, C. Temm-Grove, S. M. Sheehan, J. B. Hoying, and R. E. Allen (2009)
Am J Physiol Cell Physiol 296, C1321-C1328
 |  Abstract »  |  Full Text »  |  PDF »

Myc Regulates Embryonic Vascular Permeability and Remodeling.

E. Kokai, F. Voss, F. Fleischer, S. Kempe, D. Marinkovic, H. Wolburg, F. Leithauser, V. Schmidt, U. Deutsch, and T. Wirth (2009)
Circ. Res. 104, 1151-1159
 |  Abstract »  |  Full Text »  |  PDF »

A Role for a CXCR2/Phosphatidylinositol 3-Kinase {gamma} Signaling Axis in Acute and Chronic Vascular Permeability.

J. Gavard, X. Hou, Y. Qu, A. Masedunskas, D. Martin, R. Weigert, X. Li, and J. S. Gutkind (2009)
Mol. Cell. Biol. 29, 2469-2480
 |  Abstract »  |  Full Text »  |  PDF »

VEGF-A and i-NOS expression are prognostic factors in serous epithelial ovarian carcinomas after complete surgical resection.

K Engels, A du Bois, P Harter, A Fisseler-Eckhoff, F Kommoss, R Stauber, M Kaufmann, V Nekljudova, and S Loibl (2009)
J. Clin. Pathol. 62, 448-454
 |  Abstract »  |  Full Text »  |  PDF »

Distinct role of PLC{beta}3 in VEGF-mediated directional migration and vascular sprouting.

R. Bhattacharya, J. Kwon, X. Li, E. Wang, S. Patra, J. P. Bida, Z. Bajzer, L. Claesson-Welsh, and D. Mukhopadhyay (2009)
J. Cell Sci. 122, 1025-1034
 |  Abstract »  |  Full Text »  |  PDF »

Role and Therapeutic Potential of VEGF in the Nervous System.

C. Ruiz de Almodovar, D. Lambrechts, M. Mazzone, and P. Carmeliet (2009)
Physiol Rev 89, 607-648
 |  Abstract »  |  Full Text »  |  PDF »

Lipoxin A4: Anti-Inflammatory and Anti-Angiogenic Impact on Endothelial Cells.

N. Baker, S. J. O'Meara, M. Scannell, P. Maderna, and C. Godson (2009)
J. Immunol. 182, 3819-3826
 |  Abstract »  |  Full Text »  |  PDF »

Dysfunctional Microvasculature as a Consequence of Shb Gene Inactivation Causes Impaired Tumor Growth.

N. S. Funa, V. Kriz, G. Zang, G. Calounova, B. Akerblom, J. Mares, E. Larsson, Y. Sun, C. Betsholtz, and M. Welsh (2009)
Cancer Res. 69, 2141-2148
 |  Abstract »  |  Full Text »  |  PDF »

Vascular endothelial growth factor and angiopoietin-2 play a major role in the pathogenesis of vascular leakage in cirrhotic rats.

P Melgar-Lesmes, S Tugues, J Ros, G Fernandez-Varo, M Morales-Ruiz, J Rodes, and W Jimenez (2009)
Gut 58, 285-292
 |  Abstract »  |  Full Text »  |  PDF »

Angiogenic Factors in Plasma of Brain Tumour Patients.

A. ILHAN, W. GARTNER, D. NEZIRI, T. CZECH, W. BASE, W. H. HORL, and L. WAGNER (2009)
Anticancer Res 29, 731-736
 |  Abstract »  |  Full Text »  |  PDF »

Role of prostaglandin D2 receptor DP as a suppressor of tumor hyperpermeability and angiogenesis in vivo.

T. Murata, M. I. Lin, K. Aritake, S. Matsumoto, S. Narumiya, H. Ozaki, Y. Urade, M. Hori, and W. C. Sessa (2008)
PNAS 105, 20009-20014
 |  Abstract »  |  Full Text »  |  PDF »

Through The Eyes of a Child: Understanding Retinopathy through ROP The Friedenwald Lecture.

L. E. H. Smith (2008)
Invest. Ophthalmol. Vis. Sci. 49, 5177-5182
 |  Full Text »  |  PDF »

Maintenance Treatment with Bevacizumab Prolongs Survival in an In vivo Ovarian Cancer Model.

S. Mabuchi, Y. Terai, K. Morishige, A. Tanabe-Kimura, H. Sasaki, M. Kanemura, S. Tsunetoh, Y. Tanaka, M. Sakata, R. A. Burger, et al. (2008)
Clin. Cancer Res. 14, 7781-7789
 |  Abstract »  |  Full Text »  |  PDF »

Antitumor Effect of SN-38-Releasing Polymeric Micelles, NK012, on Spontaneous Peritoneal Metastases from Orthotopic Gastric Cancer in Mice Compared with Irinotecan.

T. Eguchi Nakajima, K. Yanagihara, M. Takigahira, M. Yasunaga, K. Kato, T. Hamaguchi, Y. Yamada, Y. Shimada, K. Mihara, T. Ochiya, et al. (2008)
Cancer Res. 68, 9318-9322
 |  Abstract »  |  Full Text »  |  PDF »

Elevated levels of placental growth factor represent an adaptive host response in sepsis.

K. Yano, Y. Okada, G. Beldi, S.-C. Shih, N. Bodyak, H. Okada, P. M. Kang, W. Luscinskas, S. C. Robson, P. Carmeliet, et al. (2008)
J. Exp. Med. 205, 2623-2631
 |  Abstract »  |  Full Text »  |  PDF »

Doxycycline induces membrane expression of VE-cadherin on endothelial cells and prevents vascular hyperpermeability.

O. Fainaru, I. Adini, O. Benny, L. Bazinet, E. Pravda, R. D'Amato, and J. Folkman (2008)
FASEB J 22, 3728-3735
 |  Abstract »  |  Full Text »  |  PDF »

Nuclear Interleukin-33 Is Generally Expressed in Resting Endothelium but Rapidly Lost upon Angiogenic or Proinflammatory Activation.

A. M. Kuchler, J. Pollheimer, J. Balogh, J. Sponheim, L. Manley, D. R. Sorensen, P. M. De Angelis, H. Scott, and G. Haraldsen (2008)
Am. J. Pathol. 173, 1229-1242
 |  Abstract »  |  Full Text »  |  PDF »

Effects of the Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235 on the Tumor Vasculature: Implications for Clinical Imaging.

C. R. Schnell, F. Stauffer, P. R. Allegrini, T. O'Reilly, P. M.J. McSheehy, C. Dartois, M. Stumm, R. Cozens, A. Littlewood-Evans, C. Garcia-Echeverria, et al. (2008)
Cancer Res. 68, 6598-6607
 |  Abstract »  |  Full Text »  |  PDF »

H-Ras Regulates Angiogenesis and Vascular Permeability by Activation of Distinct Downstream Effectors.

D. Serban, J. Leng, and D. Cheresh (2008)
Circ. Res. 102, 1350-1358
 |  Abstract »  |  Full Text »  |  PDF »

Prostacyclin analogs stimulate VEGF production from human lung fibroblasts in culture.

K. Kamio, T. Sato, X. Liu, H. Sugiura, S. Togo, T. Kobayashi, S. Kawasaki, X. Wang, L. Mao, Y. Ahn, et al. (2008)
Am J Physiol Lung Cell Mol Physiol 294, L1226-L1232
 |  Abstract »  |  Full Text »  |  PDF »

Infectious Spleen and Kidney Necrosis Virus ORF48R Functions as a New Viral Vascular Endothelial Growth Factor.

Z.-L. Wang, X.-P. Xu, B.-L. He, S.-P. Weng, J. Xiao, L. Wang, T. Lin, X. Liu, Q. Wang, X.-Q. Yu, et al. (2008)
J. Virol. 82, 4371-4383
 |  Abstract »  |  Full Text »  |  PDF »

Messenger RNA Expression of Vascular Endothelial Growth Factor and Its Receptors in Primary Colorectal Cancer and Corresponding Liver Metastasis.

H. Kobayashi, K. Sugihara, H. Uetake, T. Higuchi, M. Yasuno, M. Enomoto, H. Kuramochi, H.-J. Lenz, K. D. Danenberg, and P. V. Danenberg (2008)
Ann. Surg. Oncol. 15, 1232-1238
 |  Abstract »  |  Full Text »  |  PDF »

A Cryptic Vascular Endothelial Growth Factor T-Cell Epitope: Identification and Characterization by Mass Spectrometry and T-Cell Assays.

A. O. Weinzierl, D. Maurer, F. Altenberend, N. Schneiderhan-Marra, K. Klingel, O. Schoor, D. Wernet, T. Joos, H.-G. Rammensee, and S. Stevanovic (2008)
Cancer Res. 68, 2447-2454
 |  Abstract »  |  Full Text »  |  PDF »

Overexpression of PTEN in ovarian cancer cells suppresses i.p. dissemination and extends survival in mice.

Y. Takei, Y. Saga, H. Mizukami, T. Takayama, M. Ohwada, K. Ozawa, and M. Suzuki (2008)
Mol. Cancer Ther. 7, 704-711
 |  Abstract »  |  Full Text »  |  PDF »

Mitogen-activated protein kinase kinase signaling promotes growth and vascularization of fibrosarcoma.

Y. Ding, E. A. Boguslawski, B. D. Berghuis, J. J. Young, Z. Zhang, K. Hardy, K. Furge, E. Kort, A. E. Frankel, R. V. Hay, et al. (2008)
Mol. Cancer Ther. 7, 648-658
 |  Abstract »  |  Full Text »  |  PDF »

Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor.

L. M. Acevedo, S. Barillas, S. M. Weis, J. R. Gothert, and D. A. Cheresh (2008)
Blood 111, 2674-2680
 |  Abstract »  |  Full Text »  |  PDF »

Early Events in the Pathogenesis of Epithelial Ovarian Cancer.

C. N. Landen Jr, M. J. Birrer, and A. K. Sood (2008)
J. Clin. Oncol. 26, 995-1005
 |  Abstract »  |  Full Text »  |  PDF »

Yeast-Derived {beta}-Glucan Augments the Therapeutic Efficacy Mediated by Anti-Vascular Endothelial Growth Factor Monoclonal Antibody in Human Carcinoma Xenograft Models.

C. Salvador, B. Li, R. Hansen, D. E. Cramer, M. Kong, and J. Yan (2008)
Clin. Cancer Res. 14, 1239-1247
 |  Abstract »  |  Full Text »  |  PDF »

Characterization of Azurocidin as a Permeability Factor in the Retina: Involvement in VEGF-Induced and Early Diabetic Blood-Retinal Barrier Breakdown.

D. Skondra, K. Noda, L. Almulki, F. Tayyari, S. Frimmel, T. Nakazawa, I. K. Kim, S. Zandi, K. L. Thomas, J. W. Miller, et al. (2008)
Invest. Ophthalmol. Vis. Sci. 49, 726-731
 |  Abstract »  |  Full Text »  |  PDF »

Expression of Vascular Endothelial Growth Factor in Human Meningiomas and Peritumoral Brain Areas.

Y.-S. Ding, H.-D. Wang, K. Tang, Z.-G. Hu, W. Jin, and W. Yan (2008)
Ann. Clin. Lab. Sci. 38, 344-351
 |  Abstract »  |  Full Text »  |  PDF »

Transmyocardial Laser Revascularization and Extravascular Angiogenetic Techniques to Increase Myocardial Blood Flow.

K. A. Horvath and Y. Zhou (2008)
Card. Surg. Adult 3, 733-752
 |  Full Text »

The Effects of Intravitreous Bevacizumab on Retinal Neovascular Membrane and Normal Capillaries in Rabbits.

H. Ameri, G. J. Chader, J.-G. Kim, S. R. Sadda, N. A. Rao, and M. S. Humayun (2007)
Invest. Ophthalmol. Vis. Sci. 48, 5708-5715
 |  Abstract »  |  Full Text »  |  PDF »

Review: Side Effects of Approved Molecular Targeted Therapies in Solid Cancers.

C. Widakowich, G. de Castro Jr., E. de Azambuja, P. Dinh, and A. Awada (2007)
Oncologist 12, 1443-1455
 |  Abstract »  |  Full Text »  |  PDF »

Taming Glioblastoma: Targeting Angiogenesis.

E. T. Wong and S. Brem (2007)
J. Clin. Oncol. 25, 4705-4706
 |  Full Text »  |  PDF »

Functional VEGF and VEGF receptors are expressed in human medulloblastomas.

M. L. Slongo, B. Molena, A. M. Brunati, M. Frasson, M. Gardiman, M. Carli, G. Perilongo, A. Rosolen, and M. Onisto (2007)
Neuro-oncol 9, 384-392
 |  Abstract »  |  Full Text »  |  PDF »

Plasma Vascular Endothelial Growth Factor-A (VEGF-A) and VEGF-A Gene Polymorphism are Associated with Hydrocele Development in Lymphatic Filariasis.

A. Y. Debrah, S. Mand, M. R. Toliat, Y. Marfo-Debrekyei, L. Batsa, P. Nurnberg, B. Lawson, O. Adjei, A. Hoerauf, and K. Pfarr (2007)
Am J Trop Med Hyg 77, 601-608
 |  Abstract »  |  Full Text »  |  PDF »

Vasoactive and Permeability Effects of Vascular Endothelial Growth Factor-165 in the Term in Vitro Dually Perfused Human Placental Lobule.

P. Brownbill, G. C. McKeeman, J. C. Brockelsby, I. P. Crocker, and C. P. Sibley (2007)
Endocrinology 148, 4734-4744
 |  Abstract »  |  Full Text »  |  PDF »

The Therapeutic Efficacy of Anti Vascular Endothelial Growth Factor Antibody, Bevacizumab, and Pemetrexed against Orthotopically Implanted Human Pleural Mesothelioma Cells in Severe Combined Immunodeficient Mice.

Q. Li, S. Yano, H. Ogino, W. Wang, H. Uehara, Y. Nishioka, and S. Sone (2007)
Clin. Cancer Res. 13, 5918-5925
 |  Abstract »  |  Full Text »  |  PDF »

Extracellular RNA mediates endothelial-cell permeability via vascular endothelial growth factor.

S. Fischer, T. Gerriets, C. Wessels, M. Walberer, S. Kostin, E. Stolz, K. Zheleva, A. Hocke, S. Hippenstiel, and K. T. Preissner (2007)
Blood 110, 2457-2465
 |  Abstract »  |  Full Text »  |  PDF »

Review: Monoclonal Antibodies to the Vascular Endothelial Growth Factor Receptor-2 in Cancer Therapy.

H. Youssoufian, D. J. Hicklin, and E. K. Rowinsky (2007)
Clin. Cancer Res. 13, 5544s-5548s
 |  Abstract »  |  Full Text »  |  PDF »

Role of VEGF in maintaining renal structure and function under normotensive and hypertensive conditions.

A. Advani, D. J. Kelly, S. L. Advani, A. J. Cox, K. Thai, Y. Zhang, K. E. White, R. M. Gow, S. M. Marshall, B. M. Steer, et al. (2007)
PNAS 104, 14448-14453
 |  Abstract »  |  Full Text »  |  PDF »

Preventing Ovarian Hyperstimulation Syndrome.

M. A. Aboulghar (2007)
J. Clin. Endocrinol. Metab. 92, 2882-2884
 |  Full Text »  |  PDF »

Upregulation of Vascular Endothelial Growth Factor Receptors Flt-1 and Flk-1 Following Acute Spinal Cord Contusion in Rats.

J.-S. Choi, H.-Y. Kim, J.-H. Cha, J.-Y. Choi, S. I. Park, C. H. Jeong, S.-S. Jeun, and M.-Y. Lee (2007)
J. Histochem. Cytochem. 55, 821-830
 |  Abstract »  |  Full Text »  |  PDF »

Inhibition of Hypoxia-Induced Increase of Blood-Brain Barrier Permeability by YC-1 through the Antagonism of HIF-1{alpha} Accumulation and VEGF Expression.

W.-L. Yeh, D.-Y. Lu, C.-J. Lin, H.-C. Liou, and W.-M. Fu (2007)
Mol. Pharmacol. 72, 440-449
 |  Abstract »  |  Full Text »  |  PDF »

Multiple Variants in Vascular Endothelial Growth Factor (VEGFA) Are Risk Factors for Time to Severe Retinopathy in Type 1 Diabetes: The DCCT/EDIC Genetics Study.

H. Al-Kateb, L. Mirea, X. Xie, L. Sun, M. Liu, H. Chen, S. B. Bull, A. P. Boright, A. D. Paterson, and for the DCCT/EDIC Research Group (2007)
Diabetes 56, 2161-2168
 |  Abstract »  |  Full Text »  |  PDF »

Phase I Clinical Study of AZD2171, an Oral Vascular Endothelial Growth Factor Signaling Inhibitor, in Patients With Advanced Solid Tumors.

J. Drevs, P. Siegert, M. Medinger, K. Mross, R. Strecker, U. Zirrgiebel, J. Harder, H. Blum, J. Robertson, J. M. Jurgensmeier, et al. (2007)
J. Clin. Oncol. 25, 3045-3054
 |  Abstract »  |  Full Text »  |  PDF »

Dual Targeting of Endothelial Cells and Pericytes in Antivascular Therapy for Ovarian Carcinoma.

C. Lu, A. A. Kamat, Y. G. Lin, W. M. Merritt, C. N. Landen, T. J. Kim, W. Spannuth, T. Arumugam, L. Y. Han, N. B. Jennings, et al. (2007)
Clin. Cancer Res. 13, 4209-4217
 |  Abstract »  |  Full Text »  |  PDF »

Novel Approaches in Advancing the Treatment of Epithelial Ovarian Cancer: The Role of Angiogenesis Inhibition.

L. Martin and R. Schilder (2007)
J. Clin. Oncol. 25, 2894-2901
 |  Abstract »  |  Full Text »  |  PDF »

Inhibition of c-Src expression and activation in malignant pleural mesothelioma tissues leads to apoptosis, cell cycle arrest, and decreased migration and invasion.

A. S. Tsao, D. He, B. Saigal, S. Liu, J. J. Lee, S. Bakkannagari, N. G. Ordonez, W. K. Hong, I. Wistuba, and F. M. Johnson (2007)
Mol. Cancer Ther. 6, 1962-1972
 |  Abstract »  |  Full Text »  |  PDF »

Bevacizumab-Induced Transient Remodeling of the Vasculature in Neuroblastoma Xenografts Results in Improved Delivery and Efficacy of Systemically Administered Chemotherapy.

P. V. Dickson, J. B. Hamner, T. L. Sims, C. H. Fraga, C. Y.C. Ng, S. Rajasekeran, N. L. Hagedorn, M. B. McCarville, C. F. Stewart, and A. M. Davidoff (2007)
Clin. Cancer Res. 13, 3942-3950
 |  Abstract »  |  Full Text »  |  PDF »

Glial Cell-Derived Cytokines Attenuate the Breakdown of Vascular Integrity in Diabetic Retinopathy.

N. Nishikiori, M. Osanai, H. Chiba, T. Kojima, Y. Mitamura, H. Ohguro, and N. Sawada (2007)
Diabetes 56, 1333-1340
 |  Abstract »  |  Full Text »  |  PDF »

Intramyocardial injection of vascular endothelial growth factor gene improves cardiac performance and inhibits cardiomyocyte apoptosis.

Y. Ruixing, Y. Dezhai, W. Hai, H. Kai, W. Xianghong, and C. Yuming (2007)
Eur J Heart Fail 9, 343-351
 |  Abstract »  |  Full Text »  |  PDF »

Vascular Endothelial Growth Factors: Biology and Current Status of Clinical Applications in Cardiovascular Medicine.

S. Yla-Herttuala, T. T. Rissanen, I. Vajanto, and J. Hartikainen (2007)
J. Am. Coll. Cardiol. 49, 1015-1026
 |  Abstract »  |  Full Text »  |  PDF »

Bovine papular stomatitis virus encodes a functionally distinct VEGF that binds both VEGFR-1 and VEGFR-2.

M. K. Inder, N. Ueda, A. A. Mercer, S. B. Fleming, and L. M. Wise (2007)
J. Gen. Virol. 88, 781-791
 |  Abstract »  |  Full Text »  |  PDF »

Towards a rational approach to combination therapy for neovascular age-related macular degeneration.

J. G Arroyo (2007)
Br. J. Ophthalmol. 91, 130-131
 |  Full Text »  |  PDF »

Bevacizumab is active in malignant effusion.

O Pichelmayer, B Gruenberger, C Zielinski, and M Raderer (2006)
Ann. Onc. 17, 1853
 |  Full Text »  |  PDF »

Vascular endothelial growth factor biology: clinical implications for ocular treatments..

R B Bhisitkul (2006)
Br. J. Ophthalmol. 90, 1542-1547
 |  Abstract »  |  Full Text »  |  PDF »

Expression and Functions of the Vascular Endothelial Growth Factors and Their Receptors in Human Basophils.

A. de Paulis, N. Prevete, I. Fiorentino, F. W. Rossi, S. Staibano, N. Montuori, P. Ragno, A. Longobardi, B. Liccardo, A. Genovese, et al. (2006)
J. Immunol. 177, 7322-7331
 |  Abstract »  |  Full Text »  |  PDF »

Low-Dose Dopamine Agonist Administration Blocks Vascular Endothelial Growth Factor (VEGF)-Mediated Vascular Hyperpermeability without Altering VEGF Receptor 2-Dependent Luteal Angiogenesis in a Rat Ovarian Hyperstimulation Model.

R. Gomez, M. Gonzalez-Izquierdo, R. C. Zimmermann, E. Novella-Maestre, I. Alonso-Muriel, J. Sanchez-Criado, J. Remohi, C. Simon, and A. Pellicer (2006)
Endocrinology 147, 5400-5411
 |  Abstract »  |  Full Text »  |  PDF »

RUNX3 Inhibits the Expression of Vascular Endothelial Growth Factor and Reduces the Angiogenesis, Growth, and Metastasis of Human Gastric Cancer..

Z. Peng, D. Wei, L. Wang, H. Tang, J. Zhang, X. Le, Z. Jia, Q. Li, and K. Xie (2006)
Clin. Cancer Res. 12, 6386-6394
 |  Abstract »  |  Full Text »  |  PDF »

Blockade of Vascular Endothelial Growth Factor Signaling Ameliorates Diabetic Albuminuria in Mice.

S. H. Sung, F. N. Ziyadeh, A. Wang, P. E. Pyagay, Y. S. Kanwar, and S. Chen (2006)
J. Am. Soc. Nephrol. 17, 3093-3104
 |  Abstract »  |  Full Text »  |  PDF »

Requirement of Protein Kinase D Tyrosine Phosphorylation for VEGF-A165-induced Angiogenesis through Its Interaction and Regulation of Phospholipase C{gamma} Phosphorylation.

L. Qin, H. Zeng, and D. Zhao (2006)
J. Biol. Chem. 281, 32550-32558
 |  Abstract »  |  Full Text »  |  PDF »

Diverse effects of vascular endothelial growth factor on human pulmonary endothelial barrier and migration.

T. Mirzapoiazova, I. Kolosova, P. V. Usatyuk, V. Natarajan, and A. D. Verin (2006)
Am J Physiol Lung Cell Mol Physiol 291, L718-L724
 |  Abstract »  |  Full Text »  |  PDF »

Vascular Endothelial Growth Factor Signaling to Endothelial Nitric Oxide Synthase: More than a FLeeTing Moment.

M. I. Lin and W. C. Sessa (2006)
Circ. Res. 99, 666-668
 |  Full Text »  |  PDF »

Proteinuria with and without Renal Glomerular Podocyte Effacement.

R. Kalluri (2006)
J. Am. Soc. Nephrol. 17, 2383-2389
 |  Abstract »  |  Full Text »  |  PDF »

VEGF Activates Receptor-Operated Cation Channels in Human Microvascular Endothelial Cells.

H.-W. Cheng, A.F. James, R.R. Foster, J.C. Hancox, and D.O. Bates (2006)
Arterioscler. Thromb. Vasc. Biol. 26, 1768-1776
 |  Abstract »  |  Full Text »  |  PDF »

Insulin-like Growth Factor-I Regulates Vascular Endothelial Growth Factor Secretion by Human Oviductal Epithelial Cells and Stromal Fibroblasts.

K. Nasu, H. Itoh, A. Yuge, Y. Kawano, and H. Narahara (2006)
Reproductive Sciences 13, 368-371
 |  Abstract »  |  PDF »

Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm?.

A R L Medford and A B Millar (2006)
Thorax 61, 621-626
 |  Abstract »  |  Full Text »  |  PDF »

Tyrosine Kinase Inhibitors of Vascular Endothelial Growth Factor Receptors in Clinical Trials: Current Status and Future Directions.

A. Morabito, E. De Maio, M. Di Maio, N. Normanno, and F. Perrone (2006)
Oncologist 11, 753-764
 |  Abstract »  |  Full Text »  |  PDF »

Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality.

K. Yano, P. C. Liaw, J. M. Mullington, S.-C. Shih, H. Okada, N. Bodyak, P. M. Kang, L. Toltl, B. Belikoff, J. Buras, et al. (2006)
J. Exp. Med. 203, 1447-1458
 |  Abstract »  |  Full Text »  |  PDF »

Hepatocyte Growth Factor Induces Retinal Vascular Permeability via MAP-Kinase and PI-3 Kinase without Altering Retinal Hemodynamics..

A. C. Clermont, M. Cahill, H. Salti, S. L. Rook, C. Rask-Madsen, L. Goddard, J. S. Wong, D. Bursell, S. E. Bursell, and L. P. Aiello (2006)
Invest. Ophthalmol. Vis. Sci. 47, 2701-2708
 |  Abstract »  |  Full Text »  |  PDF »

Increased Vascular Endothelial Growth Factor and Receptors: Relationship to Angiogenesis in Asthma.

B. N. Feltis, D. Wignarajah, L. Zheng, C. Ward, D. Reid, R. Harding, and E. H. Walters (2006)
Am. J. Respir. Crit. Care Med. 173, 1201-1207
 |  Abstract »  |  Full Text »  |  PDF »

Antiangiogenic therapy: a universal chemosensitization strategy for cancer?.

R. S. Kerbel (2006)
Science 312, 1171-1175
 |  Abstract »  |  Full Text »  |  PDF »

Neovascularization in Human Atherosclerosis.

P. R. Moreno, K-R. Purushothaman, M. Sirol, A. P. Levy, and V. Fuster (2006)
Circulation 113, 2245-2252
 |  Full Text »  |  PDF »

Growth Factors and the Epididymis.

J. L. Tomsig and T. T. Turner (2006)
J Androl 27, 348-357
 |  Full Text »  |  PDF »

The angiogenic function of nucleolin is mediated by vascular endothelial growth factor and nonmuscle myosin.

Y. Huang, H. Shi, H. Zhou, X. Song, S. Yuan, and Y. Luo (2006)
Blood 107, 3564-3571
 |  Abstract »  |  Full Text »  |  PDF »

The anti-angiogenic VEGF isoform VEGF165b transiently increases hydraulic conductivity, probably through VEGF receptor 1 in vivo.

C. A. Glass, S. J. Harper, and D. O. Bates (2006)
J. Physiol. 572, 243-257
 |  Abstract »  |  Full Text »  |  PDF »

Albendazole: a Potent Inhibitor of Vascular Endothelial Growth Factor and Malignant Ascites Formation in OVCAR-3 Tumor-Bearing Nude Mice..

M. Hossein Pourgholami, Z. Yan Cai, Y. Lu, L. Wang, and D. Lawson Morris (2006)
Clin. Cancer Res. 12, 1928-1935
 |  Abstract »  |  Full Text »  |  PDF »

Targeting Angiogenesis With Integrative Cancer Therapies.

D. R. Yance Jr and S. M. Sagar (2006)
Integr Cancer Ther 5, 9-29
 |  Abstract »  |  PDF »

Peptides selected for binding to clotted plasma accumulate in tumor stroma and wounds.

J. Pilch, D. M. Brown, M. Komatsu, T. A. H. Jarvinen, M. Yang, D. Peters, R. M. Hoffman, and E. Ruoslahti (2006)
PNAS 103, 2800-2804
 |  Abstract »  |  Full Text »  |  PDF »

Review of the Effects of Anti-Angiogenic Compounds on the Epiphyseal Growth Plate.

A. P. Hall, F. R. Westwood, and P. F. Wadsworth (2006)
Toxicol Pathol 34, 131-147
 |  Abstract »  |  Full Text »  |  PDF »

Effect of Inhibition of Vascular Endothelial Growth Factor Signaling on Distribution of Extravasated Antibodies in Tumors.

T. Nakahara, S. M. Norberg, D. R. Shalinsky, D. D. Hu-Lowe, and D. M. McDonald (2006)
Cancer Res. 66, 1434-1445
 |  Abstract »  |  Full Text »  |  PDF »

Overcoming Physiologic Barriers to Cancer Treatment by Molecularly Targeting the Tumor Microenvironment.

R. Cairns, I. Papandreou, and N. Denko (2006)
Mol. Cancer Res. 4, 61-70
 |  Abstract »  |  Full Text »  |  PDF »

Vascular endothelial growth factor in the lung.

N. F. Voelkel, R. W. Vandivier, and R. M. Tuder (2006)
Am J Physiol Lung Cell Mol Physiol 290, L209-L221
 |  Abstract »  |  Full Text »  |  PDF »

Proteomic Analysis of Malignant Ovarian Cancer Effusions as a Tool for Biologic and Prognostic Profiling.

B. Davidson, V. Espina, S. M. Steinberg, V. A. Florenes, L. A. Liotta, G. B. Kristensen, C. G. Trope, A. Berner, and E. C. Kohn (2006)
Clin. Cancer Res. 12, 791-799
 |  Abstract »  |  Full Text »  |  PDF »

Influence of Treatment Parameters on Selectivity of Verteporfin Therapy.

S. Michels, F. Hansmann, W. Geitzenauer, and U. Schmidt-Erfurth (2006)
Invest. Ophthalmol. Vis. Sci. 47, 371-376
 |  Abstract »  |  Full Text »  |  PDF »

Vascular endothelial growth factor increases the ultrafiltration coefficient in isolated intact Wistar rat glomeruli.

A. H. J. Salmon, C. R. Neal, D. O. Bates, and S. J. Harper (2006)
J. Physiol. 570, 141-156
 |  Abstract »  |  Full Text »  |  PDF »

Antitumor Vascular Strategy for Controlling Experimental Metastatic Spread of Human Small-Cell Lung Cancer Cells with ZD6474 in Natural Killer Cell-Depleted Severe Combined Immunodeficient Mice.

S. Yano, H. Muguruma, Y. Matsumori, H. Goto, E. Nakataki, N. Edakuni, H. Tomimoto, S. Kakiuchi, A. Yamamoto, H. Uehara, et al. (2005)
Clin. Cancer Res. 11, 8789-8798
 |  Abstract »  |  Full Text »  |  PDF »

Errors of measurement for blood volume parameters: a meta-analysis.

C. J. Gore, W. G. Hopkins, and C. M. Burge (2005)
J Appl Physiol 99, 1745-1758
 |  Abstract »  |  Full Text »  |  PDF »

RS3PE syndrome presenting as vascular endothelial growth factor associated disorder.

K Arima, T Origuchi, M Tamai, N Iwanaga, Y Izumi, M Huang, F Tanaka, M Kamachi, K Aratake, H Nakamura, et al. (2005)
Ann Rheum Dis 64, 1653-1655
 |  Abstract »  |  Full Text »  |  PDF »

Vascular Endothelial Growth Factor-A Promotes Peritumoral Lymphangiogenesis and Lymphatic Metastasis.

M. A. Bjorndahl, R. Cao, J. B. Burton, E. Brakenhielm, P. Religa, D. Galter, L. Wu, and Y. Cao (2005)
Cancer Res. 65, 9261-9268
 |  Abstract »  |  Full Text »  |  PDF »

Response of a Nonmalignant Pleural Effusion to Bevacizumab.

O. Pichelmayer, C. Zielinski, and M. Raderer (2005)
N. Engl. J. Med. 353, 740-741
 |  Full Text »  |  PDF »

Inhibition of Vascular Permeability Factor/Vascular Endothelial Growth Factor-mediated Angiogenesis by the Kruppel-like Factor KLF2.

R. Bhattacharya, S. SenBanerjee, Z. Lin, S. Mir, A. Hamik, P. Wang, P. Mukherjee, D. Mukhopadhyay, and M. K. Jain (2005)
J. Biol. Chem. 280, 28848-28851
 |  Abstract »  |  Full Text »  |  PDF »

To Advertise   |   Find Products